Failure of Iclusig, Ariad's Pharmaceutical Drug, No Surprise to CBCD - PR Web

20-10-2013 PR WebComments (0)

Ariad PharmaceuticalsIclusigPharmaceutical

The failure of Ariad Pharmaceutical's leukemia drug, Iclusig is no surprise to the CBCD. If top management at Ariad, and/or their investors, had turned to the CBCD, the Center would have told them that the chance of completing a successful clinical ...

Read more on PR Web

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top